Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule belonging to the class of naphthalene carboxanilides. It has not been approved for any therapeutic use and is considered experimental. There are no known clinical indications, FDA or EMA approvals, or ongoing clinical trials for this molecule. Its mechanism of action and biological targets have not been characterized in publicly available sources[1][2][5]. The compound is referenced in chemical databases such as DrugBank (DB07076), ChEMBL (CHEMBL111575), and PubChem (CID: 447734)[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 6-[(Z)-amino(imino)methyl]-N-[3-(cyclopentyloxy)phenyl]-2-naphthamide.